USP32 Promotes Colorectal Carcinoma Progression Through Activating NF ‐ κB Signalling Pathway
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Xiaofan Duan und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, NF-kappa B, Signal Transduction, Ubiquitin Thiolesterase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wu Jieping Medical Foundation.
Abstract (Originalsprache)
Ubiquitin‐specific protease 32 (USP32) plays a key role in cancer progression. However, its functions in colorectal carcinoma (CRC) are still unexplored. In our study, we explored the expression and clinical significance of USP32 in CRC as well as its relationship with the tumour microenvironment (TME). As a result, we found that USP32 is overexpressed in CRC and it is associated with poor outcomes in CRC patients. In addition, the expression of USP32 is significantly related to the activation of the NF‐κB signalling pathway and the immune infiltrates of the TME. Wet experiments also confirmed that USP32 is critical for the proliferation, survival, and migration of CRC cells and tumour growth, which may be due to the activation of the NF‐κB signalling pathway. In conclusion, targeting the USP32–NF‐κB axis may be a novel treatment strategy for CRC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Tongji University, Shanghai, China.
- Department of Oncology, Shanghai GoBroad Cancer Hospital, China Pharmaceutical University, Shanghai, China.
- Department of surgical oncology, Shanghai GoBroad Cancer Hospital, China Pharmaceutical University, Shanghai, China.
- Shanghai East Hospital, Nanjing Medical University, Shanghai, China.
- Department of Oncology, Shanghai Artemed Hospital, Shanghai, China.
ORCID-Profile: Yanjun Feng
Förderung
- Wu Jieping Medical Foundation
Zitieren
APA
Duan, X., Yeerkenbieke, G., Huang, S., & Feng, Y. (2025). USP32 Promotes Colorectal Carcinoma Progression Through Activating NF ‐ κB Signalling Pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70457
Vancouver
Duan X, Yeerkenbieke G, Huang S, Feng Y. USP32 Promotes Colorectal Carcinoma Progression Through Activating NF ‐ κB Signalling Pathway. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70457
BibTeX
@article{Duan2025,
author = {Duan, Xiaofan and Yeerkenbieke, Gaoshaer and Huang, Siping and Feng, Yanjun},
title = {USP32 Promotes Colorectal Carcinoma Progression Through Activating NF ‐ κB Signalling Pathway},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70457}
}
EUVIMED